IFCT-0501

Publications:
  • Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial
  • Metastatic non-small cell lung cancer: Systemic treatment of patients aged 70 and over
  • Second-line therapy in elderly patients with advanced non-small cell lung carcinoma: analysis of the IFCT-0501 Phase III study comparing single-agent therapy to carboplatin-based doublet therapy with fixed second-line erlotinib therapy.
  • Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC)
    •